SCHEMBL4757983

SCHEMBL4757983

CS(=O)(=O)c1cnc(NC(=O)c2ccccc2)s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.61
CCNE1 P24864 2/20 0.60
CDK2 P24941 2/20 0.60
CDK5 Q00535 1/20 0.60
SCD O00767 1/20 0.56
NPC1 O15118 5/20 0.52
RAB9A P51151 5/20 0.52
ALDH1A1 P00352 1/20 0.52
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.51
TP53 P04637 1/20 0.51
PKM P14618 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
LCK P06239 1/20 0.49
FFAR2 O15552 1/20 0.49
MAPT P10636 2/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CSNK2A2 P19784 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703520 0.87 FFAR2 (0.48) KDRCCNE1CDK2CDK5SCD
SCHEMBL4757155 0.87 NPC1 (0.59) KDRCCNE1CDK2CDK5NPC1
SCHEMBL4756952 0.85 RAB9A (0.57) KDRSCDNPC1RAB9ASMN1; SMN2
SCHEMBL703165 0.85 HSD17B1 (0.51) KDRCCNE1CDK2CDK5SCD
SCHEMBL4755967 0.83 CSNK2A2 (0.47) KDRCCNE1CDK2CDK5SCD
SCHEMBL704075 0.82 STAT3 (0.58) NPC1RAB9AALDH1A1SMN1; SMN2TP53
SCHEMBL31426452 0.82 STAT3 (0.58) NPC1RAB9AALDH1A1SMN1; SMN2TP53
SCHEMBL4757584 0.82 KMT2A (0.50) KDRCCNE1CDK2CDK5NPC1
SCHEMBL702024 0.82 RAB9A (0.57) SCDNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4756954 0.82 FFAR2 (0.46) KDRCCNE1CDK2CDK5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
WO-2009035788-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2009-03-19 WO disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KDR 4456/4885CCNE1 2547/4885CDK2 200/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KDR 4456/4885CCNE1 2547/4885CDK2 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.